Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
Go back to Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives| (NASDAQ: ALLR) | Delayed: 1.34 +0.01 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.33 | 52 Week High | $ | |||
| Open | $1.36 | 52 Week Low | $ | |||
| Day High | $1.41 | P/E | N/A | |||
| Day Low | $1.34 | EPS | $ | |||
| Volume | 44,642 | |||||
| (NASDAQ: ALLR) | Delayed: 1.34 +0.01 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.33 | 52 Week High | $ | |||
| Open | $1.36 | 52 Week Low | $ | |||
| Day High | $1.41 | P/E | N/A | |||
| Day Low | $1.34 | EPS | $ | |||
| Volume | 44,642 | |||||

